1-4 of 4
Erica Hochard, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5760.
https://doi.org/10.1182/blood-2018-99-117654
Published: 2018
Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5642.
https://doi.org/10.1182/blood-2018-99-117497
Published: 2018
Journal Articles

Outcomes of Vdpace with Immunomodulator Treatment in Initial and Relapsed/Refractory Multiple Myeloma in a Single Center

Al-Ola Abdallah, MD, Joseph P. McGuirk, DO, Leyla Shune, MD, Erica Hochard, PhD, Neil Dunavin, MD, Zahra Mahmoudjafari, PhD, Siddhartha Ganguly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5422.
https://doi.org/10.1182/blood.V130.Suppl_1.5422.5422
Published: 2017
Journal Articles

Daratumumab Combined with Pomalidomide and Dexamethasone (DPd) for Patients with Relapsed/Refractory Multiple Myeloma in a Single Institution

Al-Ola Abdallah, MD, Joseph P. McGuirk, DO, Leyla Shune, MD, Neil Dunavin, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Siddhartha Ganguly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1856.
https://doi.org/10.1182/blood.V130.Suppl_1.1856.1856
Published: 2017